Stock Events

Stock Events

Schott Pharma & CO. 

$4.37
53
+$0.00+0% Thursday 20:00

Statistics

Day High
4.5
Day Low
4.5
52W High
7.65
52W Low
4.37
Volume
200
Avg. Volume
0
Mkt Cap
0
P/E Ratio
15.07
Dividend Yield
1.21%
Dividend
0.05

Upcoming

Dividends

1.21%Dividend Yield
Feb 26
$0.05
Feb 25
$0.04
Feb 25
$0.04
May 17
$0.56
Oct 16
$0.48
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
28.04%

Earnings

12AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
0.2
0.25
0.31
0.37
Expected EPS
0.30242091418
Actual EPS
0.28993020396

Financials

14.91%Profit Margin
Profitable
2023
2024
2025
1.1BRevenue
164.59MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SHTPY. It's not an investment recommendation.
Basf
8
BAS.XETRA
Allianz
7
ALV.XETRA
Volkswagen
7
VOW3.XETRA
Mercedes-Benz Group
7
MBG.XETRA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap152.69B
Pfizer Inc. competes with Schott Pharma in various therapeutic areas, including vaccines, oncology, and biopharmaceuticals, making it a direct competitor.
Merck
MRK
Mkt Cap335.14B
Merck & Co., Inc. is a competitor because of its extensive range of pharmaceutical products that overlap with Schott Pharma's market, especially in the fields of oncology and vaccines.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson is a competitor due to its large healthcare portfolio, including pharmaceuticals and biotechnology products that compete across several of Schott Pharma's key markets.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie Inc. competes with Schott Pharma in the biopharmaceutical sector, particularly in areas like immunology and oncology, where both companies have significant investments.
Novartis
NVS
Mkt Cap286.78B
Novartis AG is a competitor because of its broad range of pharmaceutical products, including generics and biosimilars, that compete with Schott Pharma's portfolio.
GSK
GSK
Mkt Cap99.18B
GlaxoSmithKline plc is a competitor in the pharmaceutical and healthcare sector, with a focus on areas like vaccines and respiratory diseases, directly competing with Schott Pharma.
Sanofi
SNY
Mkt Cap104.76B
Sanofi competes with Schott Pharma in the global healthcare market, offering products in areas like vaccines, rare diseases, and multiple sclerosis.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a competitor due to its strong presence in oncology, immunology, and infectious diseases, areas where Schott Pharma also operates.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol-Myers Squibb Company competes with Schott Pharma in the pharmaceutical sector, particularly in oncology and cardiovascular diseases, making it a direct competitor.

About

SCHOTT PHARMA AG&CO ADR
Show more...
CEO
Mr. Christian Mias
Country
United States
ISIN
US8080381036
WKN
000A40AE0

Listings

F
DE
1SX.F
MI
IT
1SXP.MI
F
DE
1SXP.F
MU
DE
1SXP.MU

0 Comments

Share your thoughts

FAQ

What is Schott Pharma & CO. stock price today?▼
The current price of SHTPY is $4.37 USD — it has increased by +0% in the past 24 hours. Watch Schott Pharma & CO. stock price performance more closely on the chart.
What is Schott Pharma & CO. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Schott Pharma & CO. stocks are traded under the ticker SHTPY.
When is the next Schott Pharma & CO. earnings date?▼
Schott Pharma & CO. is going to release the next earnings report on December 10, 2026.
What were Schott Pharma & CO. earnings last quarter?▼
SHTPY earnings for the last quarter are 0.29 USD per share, whereas the estimation was 0.3 USD resulting in a -4.13% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Schott Pharma & CO. revenue for the last year?▼
Schott Pharma & CO. revenue for the last year amounts to 1.1B USD.
What is Schott Pharma & CO. net income for the last year?▼
SHTPY net income for the last year is 164.59M USD.
Does Schott Pharma & CO. pay dividends?▼
Yes, SHTPY dividends are paid annual. The last dividend per share was 0.05 USD. As of today, Dividend Yield (FWD)% is 1.21%.
In which sector is Schott Pharma & CO. located?▼
Schott Pharma & CO. operates in the Other sector.
When did Schott Pharma & CO. complete a stock split?▼
Schott Pharma & CO. has not had any recent stock splits.
Where is Schott Pharma & CO. headquartered?▼
Schott Pharma & CO. is headquartered in Mainz, United States.